Screener
Dianthus Therapeutics DNTH Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Dianthus Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Dianthus Therapeutics’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001690585-26-000022
FAQ
- What is Dianthus Therapeutics's price / book?
- Dianthus Therapeutics (DNTH) reported price / book of 3.7× in Q1 2026.
- How has Dianthus Therapeutics's price / book changed year-over-year?
- Dianthus Therapeutics's price / book increased by 108.5% year-over-year, from 1.8× to 3.7×.
- What is the long-term trend for Dianthus Therapeutics's price / book?
- Over 3 years (2020 to 2025), Dianthus Therapeutics's price / book has grown at a 10.6% compound annual growth rate (CAGR), from 2.6× to 3.6×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Dianthus Therapeutics's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude